A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema

NCT04432831 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1479

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Faricimab
OTHER: Sham Procedure

Sponsor

Hoffmann-La Roche